LSI is Officially Heading to Singapore — Register for LSI Asia '25 Today

Adaptimmune

Optimization of T cell receptors (TCRs) for use in adoptive T cell therapy - to target and destroy cancerous/infected cells.

Get a Demo and See the Full Profile

Get a demo today to see profiles of Adaptimmune plus 6131 other startups.

Learn More About Adaptimmune

Technology/product details

Competing Startups

More